Cargando…
Bisoprolol in the treatment of chronic heart failure
Bisoprolol fumarate is a highly selective beta-1 receptor blocker. Bisoprolol has been extensively studied in three large mortality trials in stable chronic heart failure (CHF) patients. The CIBIS trial enrolled 641 patients and demonstrated the good tolerability of bisoprolol in a large CHF populat...
Autores principales: | de Groote, Pascal, Ennezat, Pierre-Vladimir, Mouquet, Fréderic |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291328/ https://www.ncbi.nlm.nih.gov/pubmed/17969374 |
Ejemplares similares
-
Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results
por: Metra, Marco, et al.
Publicado: (2007) -
Effects of bisoprolol in combination with trimetazidine on the treatment of heart failure and concomitant chronic obstructive pulmonary disease
por: Ke, Yuanyuan, et al.
Publicado: (2016) -
Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease
por: Su, Vincent Yi-Fong, et al.
Publicado: (2016) -
Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease: Erratum
Publicado: (2016) -
The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
por: Choi, Ki Hong, et al.
Publicado: (2019)